107 related articles for article (PubMed ID: 14744563)
1. The hexose transporter of Plasmodium falciparum is a worthy drug target.
Joët T; Krishna S
Acta Trop; 2004 Feb; 89(3):371-4. PubMed ID: 14744563
[TBL] [Abstract][Full Text] [Related]
2. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
[TBL] [Abstract][Full Text] [Related]
3. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T; Eckstein-Ludwig U; Morin C; Krishna S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
[TBL] [Abstract][Full Text] [Related]
4. Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality.
Slavic K; Straschil U; Reininger L; Doerig C; Morin C; Tewari R; Krishna S
Mol Microbiol; 2010 Mar; 75(6):1402-13. PubMed ID: 20132450
[TBL] [Abstract][Full Text] [Related]
5. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
[TBL] [Abstract][Full Text] [Related]
6. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
[TBL] [Abstract][Full Text] [Related]
7. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
Ionita M; Krishna S; Léo PM; Morin C; Patel AP
Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
[TBL] [Abstract][Full Text] [Related]
8. Docking, QM/MM, and molecular dynamics simulations of the hexose transporter from Plasmodium falciparum (PfHT).
Fonseca AL; Nunes RR; Braga VM; Comar M; Alves RJ; Varotti Fde P; Taranto AG
J Mol Graph Model; 2016 May; 66():174-86. PubMed ID: 27131282
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
[TBL] [Abstract][Full Text] [Related]
10. New antimalarial targets: the example of glucose transport.
Patel AP; Staines HM; Krishna S
Travel Med Infect Dis; 2008; 6(1-2):58-66. PubMed ID: 18342277
[TBL] [Abstract][Full Text] [Related]
11. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
[TBL] [Abstract][Full Text] [Related]
12. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of
Won JY; Mazigo E; Cha SH; Han JH
Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
[No Abstract] [Full Text] [Related]
14. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
Woodrow CJ; Burchmore RJ; Krishna S
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
[TBL] [Abstract][Full Text] [Related]
15. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
[TBL] [Abstract][Full Text] [Related]
16. Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.
Slavic K; Krishna S; Derbyshire ET; Staines HM
Malar J; 2011 Jun; 10():165. PubMed ID: 21676209
[TBL] [Abstract][Full Text] [Related]
17. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
[TBL] [Abstract][Full Text] [Related]
18. An expression system to screen for inhibitors of parasite glucose transporters.
Feistel T; Hodson CA; Peyton DH; Landfear SM
Mol Biochem Parasitol; 2008 Nov; 162(1):71-6. PubMed ID: 18708094
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O-3-hexose derivative.
Saliba KJ; Krishna S; Kirk K
FEBS Lett; 2004 Jul; 570(1-3):93-6. PubMed ID: 15251446
[TBL] [Abstract][Full Text] [Related]
20. Preferential targeting of human erythrocytes infected with the malaria parasite Plasmodium falciparumvia hexose transporter surface proteins.
Heikham KD; Gupta A; Kumar A; Singh C; Saxena J; Srivastava K; Puri SK; Dwivedi AK; Habib S; Misra A
Int J Pharm; 2015 Apr; 483(1-2):57-62. PubMed ID: 25666024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]